Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Rixathon 500 mg concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
rituximab
Company:  
Sandoz Limited See contact details
ATC code: 
L01FA01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Rixathon (rituximab) - IV administration only

{healthcare_pro_orange} For Healthcare Professionals
A healthcare professional card highlighting the route of administration for Rixathon Healthcare Professional
{pdf_link}

Rixathon (rituximab) Healthcare Professional Educational Leaflet - Important safety information for healthcare professionals in treating patients with Rixathon therapy

{healthcare_pro_orange} For Healthcare Professionals
This guide is intended to review key facts and important safety information about rituximab in non-oncology diseases and to provide important patient counselling information to assist healthcare professionals in caring for patients receiving rituximab therapy.
{pdf_link}

Rixathon (Rituximab) Patient Alert Card

Patient alert card
{pdf_link}

Rixathon (rituximab) Patient Educational Leaflet - Important safety information for patients receiving Rixathon therapy

The information provided in this booklet should be discussed with patients by their healthcare professional during Rixathon(rituximab) treatment.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Sandoz Limited
Company image
Address
Park View, Riverside Way, Watchmoor Park, Camberley, Surrey, GU15 3YL, UK
WWW
http://www.sandoz.uk.com
WWW
https://pvi1j.solutions.iqvia.com
Telephone
+44 (0) 1276 698020
Medical Information Direct Line
+44 (0)1276 698 101
Medical Information e-mail
[email protected]
Adverse event reporting email
[email protected]
Customer Care direct line
+44 (0)1276 698020
E-mail
[email protected]
E-mail
[email protected]